Cargando…
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Migraine is a very disabling disorder with severe impact on patients’ lives and substantive costs to society in terms of healthcare costs and lost productivity. Prevention is a key component of migraine therapy, and while numerous preventive options exist, each is burdened by either troublesome side...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486583/ https://www.ncbi.nlm.nih.gov/pubmed/28653227 http://dx.doi.org/10.1007/s11940-017-0463-4 |